 CANTEL MEDICAL CORP. NYSE: CMD Cantel or the Company today announced its intention to offer, subject to market and other conditions, 150 million aggregate principal amount of convertible senior notes due 2025 the Notes in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended the Securities Act. The Company also intends to grant the initial purchasers of the Notes an option to purchase up to an additional 22.5 million aggregate principal amount of Notes in the private placement. 